MDRA yields 9732.36% · PFE yields 6.13%● Live data
📍 MDRA pulled ahead of the other in Year 1
Combined, MDRA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MDRA + PFE for your $10,000?
Medra Corporation engages in the acquisition, development, and commercial exploitation of hydrogen-based technologies. The company primarily concentrates on fuel cells, hydrogen-specific sensors, and hydrogen safety. It seeks out technologies, secures those technologies through licensing agreements with the patent holders, and converts the technologies into viable products that it then produces and sells. DCH manufactures and sells a line of hydrogen sensors that are both mobile (a hand held unit) and stationary (wall ceiling or conduit mounted units) to a range of industries and customers. The company also develops, manufactures, and sells fuel cells that range from 12 watts to five kilo watts. Its H2SCAN hydrogen-specific sensing systems offer an alternative to gas detectors used in various industries, including food processing, petrochemical production, semiconductor manufacturing, and glass and metals processing. The company has licenses to various technologies, including The Robust Hydrogen Sensor, The Thick Film Hydrogen Sensor, and The Proton Exchange Membrane Fuel Cell. Medra Corporation was founded in 1994 and is based in Valencia, California.
Full MDRA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.